Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Proprietary names protection

It has now gained acceptance as an impressed current anode for cathodic protection and has been in use for this purpose since 1971. The anode consists of a thin film of valve and precious metal oxides baked onto a titanium substrate and when first developed was given the proprietary name dimensionally stable anode , sometimes shortened to DSA. Developments on the composition of the oxide film have taken place since Beer s patent, and this type of anode is now marketed under a number of different trade names. [Pg.172]

A brand name drug is a drug marketed under a proprietary, trademark-protected name. [Pg.491]

Trade name The name given to a drug by the pharmaceutical company it is protected by a trademark and used by the company for marketing the drug (SYN proprietary name). [Pg.631]

Names not protected under a registered trademark WHO recommended non-proprietary names WHO unprotected non-proprietary names... [Pg.164]

The dihydro-chloride salt of 2,7-bis(2-(diethylamino)ethoxy)-fluoren-9-one, referred to as tilorone hydrochloride (non-proprietary name) or bis-DEAE-fluorenone, is a broad spectrum antiviral compound44) with antitumor activity45-47). Mayer and coworkers48 49) have identified this compound as an interferon inducer and established a relationship with the antiviral activity. However, recently a lack of correlation between interferon induction and viral protection by tilorone hydrochloride has been reported50). [Pg.124]

Clonazepam, proprietary name Clonopin, is a benzodiazepine with chemical structure closely related to diazepam. The mechanism of action is the same as described for diazepam, but tolerance does not develop as rapidly as with diazepam. Clonazepam is currently approved for use in absence seizures, infantile spasms, akinetic seizures, and Lennox-Gastaut syndrome. Plasma concentrations associated with maximal effectiveness of the drug range from 15 to 60 ng/mL. At concentrations higher than 80 ng/mL, no additional seizure protection is observed, and toxicity (drowsiness and ataxia) ensues. The most suitable methods adaptable to routine analysis are based on GLC with electron capture detection, although HPLC methods also are effective. ... [Pg.1255]

The American Spice Trade Association (ASTA) (4) accepts spice as any dried plant product used primarily for seasoning purposes. This broad definition was designed so that items labeled only as spice could give adequate protection to proprietary formulas for spice mixtures. However, ASTA recommends that the dehydrated vegetables and the color spices be listed separately by name on all labels. ASTA also has recommended that the capsicums, no matter the species, be delisted as spices and labeled separately. [Pg.23]

A trademark is the drug s proprietary trade name and is usually registered this registered name may be legally protected... [Pg.103]

The example of Voltarol Retard, cited in the preceding section, is one of a company which has developed an innovative drag, acting to protect its franchise in that product when patent expiry draws near. Every proprietary product eventually loses its patent exclusivity (usually 20 years after the patent was applied for or granted) and it is then open to any other manufacturer to manufacture and sell the same drag, perhaps under its own brand name. It is, of course, necessary to obtain a license to manufacture and market the... [Pg.45]

The following examples are intended to illustrate the role that E-R plays in determining optimal dosing in various circumstances. The drug names have been masked to protect proprietary information however, the principles of applying E-R information are clearly outlined. [Pg.939]

The reactions to be considered here are shown in Figure 1. Of the ten or so simultaneous reactions, only two are desired. Although no chemical names will be used to protect proprietary information, it is felt that the usefulness and the capabilities of the model can be explained properly with letters as names. [Pg.93]

Where the corrosion resistance of a coating depends upon its passivity, it is common to follow plating with a conversion coating process to strengthen the passive film. Zinc, cadmium and tin in particular are treated with chromate solutions which thicken their protective oxides and also incorporate in it complex chromates (see Section 1S.3). There are many proprietary processes, especially for zinc and cadmium. Simple immersion processes are used for all three coatings, while electrolytic passivation is us on tinplate lines. Chromate immersion processes are known to benefit copper, brass and silver electrodeposits, and electrolytic chromate treatments improve the performance of nickel and chromium coatings, but they are not used to the extent common for the three first named. [Pg.393]

Gas phase process technology is widely available and is offered by several technology providers, namely Univation, BP, Basell, etc. The set up of gas phase processes is, in principle, generic and proprietary information on condensing mode, dual reactor operation, catalyst systems, etc. is protected through patents. [Pg.37]

All proprietary drug names and brand names in Chapters 22—IS are protected by their respective registered trademarks. [Pg.752]


See other pages where Proprietary names protection is mentioned: [Pg.94]    [Pg.333]    [Pg.98]    [Pg.43]    [Pg.572]    [Pg.42]    [Pg.310]    [Pg.1010]    [Pg.291]    [Pg.477]    [Pg.144]    [Pg.100]    [Pg.242]    [Pg.264]    [Pg.460]    [Pg.144]    [Pg.1891]    [Pg.379]    [Pg.568]    [Pg.27]    [Pg.411]    [Pg.252]    [Pg.274]    [Pg.758]    [Pg.759]    [Pg.213]    [Pg.380]    [Pg.73]   


SEARCH



Proprietary

© 2024 chempedia.info